Skip to main content
Skip to footer
Company
About
Leadership
Careers
Science
Genflow Biosciences
Product Pipeline
Clinical Programs
Investors
Investor Relations
Advisers
Committees
Corporate Governance
ESG
RNS
Major Shareholders
News & Media
Insights
Publications
Media Assets
Search site
Search
×
Contact
GENF-Approval of 4 Million Wallonia and 2026 Priorities
January 29, 2026
Home
About
Leadership
Genflow Biosciences
Product Pipeline
Clinical Programs
Investors
Advisers
Committees
Corporate Governance
ESG
Contact
Publications